Lockup expiration coming up. It will be below the IPO price so no one will want to sell it. Just be patient be this will be a 10 bagger one day.
Earnings report looks good. Cut the loss way down.
Yes but DRYS had much smaller float at that time. The company issued new shares to raise money over the years. The reverse split with shrink the float once again. It really has no bearing on the stock performance.
Massive Class action lawsuit coming
Too risky to stay short forever with a biotech.
This ran way up going into the conference. Now that the news is out people are taking their big profits from the $40 levels.